Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope

Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase... Tissue transglutaminase (TG2) catalyzed glutamine deamidation within gluten peptides plays a major role in the pathogenesis of celiac disease. Recent studies reported gliadin deamidation by microbial transglutaminase (MTG) and hypothesize an impact on celiac disease incidence. We therefore investigated deamidation and transamidation activities of MTG and human TG2 based on a wheat gliadin peptide containing an immunodominant epitope for celiac disease. Deamidation activity of MTG was about a magnitude lower than transamidation with a maximum at pH 5 and decreasing values at neutral and basic pH. In contrast, TG2-deamidation reaction rate doubled from pH 6 to pH 7. Transamidation activity of MTG showed minor pH dependence, whereas for TG2 it strongly increased from pH 6 to 7 by a factor of 7.5. Additionally, deamidation by TG2 in the presence of a fivefold excess of amine substrate was observed for reactions at pH 6 at an equal rate to transamidation, while at neutral pH no deamidation occurred. MTG only catalyzed deamidation in addition to transamidation when the substrate ratio was below a 2.5 fold excess of amine. In conclusion, transamidation activity rates of MTG and TG2 were higher compared to deamidation rates. In contrast to TG2, MTG shows a strong and pH-independent transamidation preference. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cereal Science Elsevier

Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope

Loading next page...
 
/lp/elsevier/microbial-transglutaminase-has-a-lower-deamidation-preference-than-AuB0cGZLWR
Publisher
Elsevier
Copyright
Copyright © 2016 Elsevier Ltd
ISSN
0733-5210
eISSN
1095-9963
D.O.I.
10.1016/j.jcs.2016.05.022
Publisher site
See Article on Publisher Site

Abstract

Tissue transglutaminase (TG2) catalyzed glutamine deamidation within gluten peptides plays a major role in the pathogenesis of celiac disease. Recent studies reported gliadin deamidation by microbial transglutaminase (MTG) and hypothesize an impact on celiac disease incidence. We therefore investigated deamidation and transamidation activities of MTG and human TG2 based on a wheat gliadin peptide containing an immunodominant epitope for celiac disease. Deamidation activity of MTG was about a magnitude lower than transamidation with a maximum at pH 5 and decreasing values at neutral and basic pH. In contrast, TG2-deamidation reaction rate doubled from pH 6 to pH 7. Transamidation activity of MTG showed minor pH dependence, whereas for TG2 it strongly increased from pH 6 to 7 by a factor of 7.5. Additionally, deamidation by TG2 in the presence of a fivefold excess of amine substrate was observed for reactions at pH 6 at an equal rate to transamidation, while at neutral pH no deamidation occurred. MTG only catalyzed deamidation in addition to transamidation when the substrate ratio was below a 2.5 fold excess of amine. In conclusion, transamidation activity rates of MTG and TG2 were higher compared to deamidation rates. In contrast to TG2, MTG shows a strong and pH-independent transamidation preference.

Journal

Journal of Cereal ScienceElsevier

Published: Jul 1, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off